These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8498499)

  • 21. Follicle-stimulating hormone is secreted more irregularly than luteinizing hormone in both humans and sheep.
    Pincus SM; Padmanabhan V; Lemon W; Randolph J; Rees Midgley A
    J Clin Invest; 1998 Mar; 101(6):1318-24. PubMed ID: 9502773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
    Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
    J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone ontogeny in the ovine fetus. XXVII. Pulsatile and copulsatile secretion of luteinizing hormone, follicle-stimulating hormone, growth hormone, and prolactin in late gestation: a new method for the analysis of copulsatility.
    Albers N; Bettendorf M; Herrmann H; Kaplan SL; Grumbach MM
    Endocrinology; 1993 Feb; 132(2):701-9. PubMed ID: 8425489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion.
    Reame N; Sauder SE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Aug; 59(2):328-37. PubMed ID: 6429184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex hormones in amenorrheic women with alcoholic liver disease.
    Välimäki M; Pelkonen R; Salaspuro M; Härkönen M; Hirvonen E; Ylikahri R
    J Clin Endocrinol Metab; 1984 Jul; 59(1):133-8. PubMed ID: 6427268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency of pulsatile luteinizing hormone-releasing hormone treatment and luteinizing hormone and follicle-stimulating hormone secretion in women with amenorrhea of suprapituitary origin.
    Lambalk CB; Schoemaker J; van Rees GP; van Dieten HA
    Fertil Steril; 1989 Mar; 51(3):416-22. PubMed ID: 2493401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Messinis IE
    Hum Reprod; 2009 Apr; 24(4):976-81. PubMed ID: 19095668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB; Martin KA; Taylor E; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal coupling of luteinizing hormone and follicle stimulating hormone secretion in polycystic ovary syndrome.
    Zarković M; Cirić J; Penezić Z; Trbojević B; Drezgić M
    Gynecol Endocrinol; 2001 Oct; 15(5):381-8. PubMed ID: 11727361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea.
    Burger CW; Korsen T; van Kessel H; van Dop PA; Caron FJ; Schoemaker J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1126-32. PubMed ID: 3932449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.